Search

Ashok Ramesh Dongre

from Sudbury, MA
Age ~56
Get Report
Also known as:
Ashok R Dongre, Ashok A Dongre, Ramesh P Dongre, Ashok R Dongres, Ashwini Dongre
Phone and address:
183 Greystone Ln, North Sudbury, MA 01776
(978) 579-8999
Related to:
Jessica Dongre
Connected to:
Archana R Dongre, 49Kiran J Dongre, 46Megan A Dongvillo, 47Flora L Dongvort, 95Ashley Donham, 33Barbara C Donham, 88Christy M Donham, 55Danny G Donham, 42Mark S Donham, 63Monika Donham, 57

Ashok Dongre Phones & Addresses

  • 183 Greystone Ln, Sudbury, MA 01776 (978) 579-8999
  • 2 Lotus Pl, Newtown, PA 18940 (215) 579-1715
  • 79 Oneill Ct, Trenton, NJ 08648 (609) 689-0048
  • Lawrenceville, NJ
  • Richmond, VA
  • Buck, PA
  • Seattle, WA
  • 2 Lotus Pl, Newtown, PA 18940 (215) 287-1620

Work

Position: Production Occupations

Education

Degree: Associate degree or higher

Emails

a***[email protected]

Publications

Us Patents

Biomarkers And Methods For Determining Sensitivity To Insulin Growth Factor-1 Receptor Modulators

View page
US Patent:
8492328, Jul 23, 2013
Filed:
May 15, 2008
Appl. No.:
12/600504
Inventors:
Fei Huang - Princeton NJ, US
Xia Han - Pennington NJ, US
Rameh Hafezi - Franklin Park NJ, US
Jiwen Chen - Bridgewater NJ, US
Douglas Michael Robinson - Hanover MA, US
Gayle M. Wittenberg - Princeton NJ, US
Ashok Ramesh Dongre - Newtown PA, US
Joan M. Carboni - Yardley PA, US
Ricardo M. Attar - Lawrenceville NJ, US
Warren Hurlburt - Mount Laurel NJ, US
Marco M. Gottardis - Princeton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A01N 61/00
G01N 33/53
US Classification:
514 1, 435 71
Abstract:
IGF1R biomarkers useful in a method for identifying and monitoring a mammal that will respond therapeutically to a method of treating cancer comprising administering an IGF1R modulator, wherein the method comprises (a) exposing the mammal to the IGF1R modulator and (b) measuring in the mammal the level of the at least one biomarker, wherein a difference in the level of the at least one biomarker measured in (b) compared to the level of the biomarker in a mammal that has not been exposed to the IGF1R modulator indicates that the mammal will respond therapeutically to the method of treating cancer and (c) wherein the level of the biomarker in a mammal after exposure to a IGF1R modulator indicates that the mammal has responded therapeutically to the method of treating cancer.

Methods Of Inhibiting Quiescent Tumor Proliferation

View page
US Patent:
20100233172, Sep 16, 2010
Filed:
Dec 16, 2009
Appl. No.:
12/639083
Inventors:
Roberto Weinmann - Princeton NJ, US
Rameh Hafezi - Franklin Park NJ, US
Arthur M.P. Doweyko - Vero Beach FL, US
Ashok Ramesh Dongre - Newtown PA, US
Deborah L. Roussell - Trenton NJ, US
Robert F. Carney - Wilmington DE, US
International Classification:
A61K 39/395
A61P 35/00
A61K 31/713
A61K 38/16
A61K 31/5513
G01N 33/567
G01N 33/573
C12N 5/09
G01N 33/53
US Classification:
4241351, 4241741, 514 44 A, 514 12, 514221, 435 723, 435 721, 435 74, 435366, 435 71
Abstract:
Improved compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders, and methods of screening to identify compounds for such treatments.

Biomarkers And Methods For Determining Sensitivity To Epidermal Growth Factor Receptor Modulators

View page
US Patent:
20110269139, Nov 3, 2011
Filed:
Jan 6, 2010
Appl. No.:
13/143228
Inventors:
Ji Gao - Cranbury NJ, US
Gayle M. Wittenberg - Plainsboro NJ, US
Douglas Michael Robinson - Hanover MA, US
Ashok Ramesh Dongre - Newtown PA, US
International Classification:
C12Q 1/68
C12Q 1/02
G01N 21/64
G01N 33/559
G01N 30/02
G01N 21/55
G01N 27/26
G01N 33/566
H01J 49/26
US Classification:
435 612, 435 721, 435 71, 435 792, 435 29, 436501, 250282, 73 6152, 356445, 204450, 204456
Abstract:
The present invention provides methods useful for predicting the likelihood that a mammal that will respond therapeutically to a method of treating cancer comprising administering an EGFR modulator, and diagnostic methods and kits thereof.

Method Of Analyzing Differential Expression Of Proteins In Proteomes By Mass Spectrometry

View page
US Patent:
8030089, Oct 4, 2011
Filed:
Jul 16, 2004
Appl. No.:
10/893415
Inventors:
Scott Geromanos - Middletown NJ, US
Ashok R. Dongre - Newtown PA, US
Gregory Opiteck - Montreal, CA
Jeffrey Silva - Beverly MA, US
Assignee:
Micromass UK Limited
International Classification:
G01N 24/00
US Classification:
436173, 436 86
Abstract:
A method of identifying molecules of biological origin is disclosed. The molecules are identified and the basis of the accurately determined mass to charge ratio of the molecules and at least a further physico-chemical property such as elution time or charge state. Further physico-chemical properties may be used. The experimentally determined accurate mass and physico-chemical properties can then be compared with a look-up table of information. The look-up table may generated or physico-chemical properties of data in a conventional database may be calculated. The ability to recognize and preferably identify the same molecules in two different samples may be used to determine whether a particular biological molecules has been expressed differently in an experimental sample relative to a control sample.
Control profile
Ashok Ramesh Dongre from Sudbury, MA, age ~56 Get Report